Change Agents appoints Eric Weisblum as independent director
CHGA•Change Agents appointed Eric Weisblum as an independent director on October 14, effective October 12, 2026. He will serve on the audit, compensation, and nominating and corporate governance committees.
1. Director appointment
Change Agents appointed Eric Weisblum as an independent director on October 14, 2026, effective October 12. He will serve on the audit, compensation, and nominating and corporate governance committees. Weisblum founded biopharmaceutical company Silo Pharma and has served as its CEO since 2020; he also has prior investment banking and capital markets experience.
